DOJ announces $2M for Florida to combat illegal manufacture, distribution of opioids

DOJ announces $2M for Florida to combat illegal manufacture, distribution of opioids

The Florida Department of Law Enforcement will receive over $2 million to combat the illegal manufacture and distribution of methamphetamine and opioids thanks to a grant from the U. S. Department of Justice.

On Friday, the US DOJ’s Office of Community Oriented Policing Services (COPS) announced it would be distributing more than $42 million to law enforcement agencies in 14 states as part of its Anti-Methamphetamine and Anti-Heroin task force programs.

The Florida’s Department of Law Enforcement will receive $2,208,052 million to support investigations into trafficking in heroin, fentanyl or carfentanil, or the unlawful distribution of prescription opioids.

“The award of this funding to the Florida Department of Law Enforcement is a tangible demonstration of the Justice Department and U.S Attorneys’ commitment to our partnerships with law enforcement agencies at all levels. We will continue to implement every tool at our disposal to combat the national epidemic of opioid abuse and misuse,” said Lawrence Keefe, U.S. Attorney for the Northern District of Florida.

The COPS Office is awarding more than $29.7 million in grant funding through the Anti-Heroin Task Force and $12 million through the Anti-Methamphetamine Program. Both of these programs will provide three years of funding to state-level law enforcement agencies in states that have high levels of opioid and methamphetamine traffic.

Officials said the programs have both proven to be successful. Between October 2019 and February 2020, the DOJ said, current grantees reported the seizure of more than $11 million in cash and more than 2,700 firearms.

“The scourge of opioid and methamphetamine use continues to take a devastating toll on our nation’s communities,” said COPS Office Director Phil Keith. “By providing these resources to law enforcement to help combat the further spread, the COPS Office is demonstrating our commitment to this Administration’s priority of reducing drug use and protecting our citizens from this public health and safety crisis.”